Lymphocyte activation gene-3 fusion protein increases the potency of a granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy.

Abstract

PURPOSE The purpose of the present study was to evaluate granulocyte macrophage colony-stimulating factor (GM-CSF)-secreting tumor cell immunotherapy, which is known to stimulate a potent and long-lasting antigen-specific immune response in combination with lymphocyte activation gene-3 fusion protein (LAG-3Ig), which has been shown to act as an adjuvant for… (More)
DOI: 10.1158/1078-0432.CCR-07-5200

Topics

Cite this paper

@article{Li2008LymphocyteAG, title={Lymphocyte activation gene-3 fusion protein increases the potency of a granulocyte macrophage colony-stimulating factor-secreting tumor cell immunotherapy.}, author={Betty H Li and Melinda Vanroey and Fr{\'e}d{\'e}ric Triebel and Karin Jooss}, journal={Clinical cancer research : an official journal of the American Association for Cancer Research}, year={2008}, volume={14 11}, pages={3545-54} }